Journal of Interferon & Cytokine Research

Special Issue on Cancer Associated Inflammation: Role of Cytokines and Interferons

Guest Editors:

Howard A. Young, PhD
Senior Investigator, Cancer and Inflammation Program
Head, Cellular and Molecular Immunology Section
Center for Cancer Research
National Cancer Institute
Balamurugan Kuppusamy, PhD
Scientist, Laboratory of Cell and Developmental Signaling
Center for Cancer Research
National Cancer Institute

In this special issue, several leaders in the field discuss the latest developments in our understanding of cancer-associated inflammation, with a focus on the role of inflammatory cytokines and interferons. Emphasis is also placed on identifying opportunities and developing road maps for novel treatment approaches to combine immunotherapies with direct modulation of cytokine levels in the host.

Click here to read the entire special issue FREE through February 5, 2019.

Journal of Interferon & Cytokine Research (JICR) provides authoritative, peer-reviewed research, analysis, and advances on the therapeutic role of cytokines and IFNs. The Journal delivers current findings on emerging topics in this niche community, including the role of IFNs in the therapy of diseases such as multiple sclerosis, the understanding of the third class of IFNs, and the identification and function of IFN-inducible genes. JICR is an official journal of the International Cytokine & Interferon Society.

278 total views, 1 views today